Impact of Preadmission Morphine on Reinfarction in Patients With ST‐Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta‐Analysis
- 28 January 2020
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 108 (1) , 54-62
Abstract
Opiates are the traditional analgesics used in patients with ST‐elevation myocardial infarction (STEMI). Pharmacodynamic studies indicate that opiates delay the absorption of orally administered P2Y12 inhibitors and the onset of platelet inhibition. Whether these negative effects on platelet inhibition have an impact on clinical outcomes is unclear. A systematic review and meta‐analysis was performed searching PubMed, MEDLINE, and Cochrane Central Register of Controlled Trials to identify studies comparing morphine and no‐morphine treatment in STEMI patients undergoing primary percutaneous coronary intervention. The primary end point was the occurrence of in‐hospital myocardial infarction, and secondary end points were in‐hospital stroke and death. Four observational studies were identified, including 3,220 patients with STEMI. Morphine‐treated patients had a higher unadjusted rate of reinfarction compared with patients not receiving morphine (1.5% vs. 0.67%, odds ratio (OR) 2.41; 95% confidence interval (CI), 1.11–5.21; P = 0.03). Unadjusted mortality rate was lower in morphine‐treated patients (1.7% vs. 4.2%, OR 0.43, 95% CI, 0.23–0.81; P = 0.009). Exclusion of the study with baseline differences between groups showed more frequent reinfarction in the morphine group, but this was no longer statistically significant (1.3% vs. 0.5%, OR 2.02; 95% CI, 0.39–10.43; P = 0.40). There was no difference in stroke according to morphine treatment. Patients pretreated with morphine appear to have a higher rate of reinfarction than patients not receiving morphine. This may be attributable to opiate‐related delay in P2Y12 inhibitor absorption and resultant delay in onset of platelet inhibition. These concerning findings indicate the need for prospective, randomized trials to assess the impact of opiates on clinical outcomes in STEMI.Keywords
This publication has 43 references indexed in Scilit:
- Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thrombosesInternational Journal of Cardiology, 2013
- Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction PatientsJACC, 2013
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryCirculation, 2013
- Effect of Narcotic Treatment on Outcomes of Acute Coronary SyndromesThe American Journal of Cardiology, 2010
- Bivalirudin during Primary PCI in Acute Myocardial InfarctionNew England Journal of Medicine, 2008
- Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement InitiativeAmerican Heart Journal, 2005
- Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)The American Journal of Cardiology, 2004
- A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction – the MEMO studyJournal of Internal Medicine, 1999
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Inhibition of gastric emptying and drug absorption by narcotic analgesics.British Journal of Clinical Pharmacology, 1975